The Next Chapter of B7-H3: From Systemic Disease to the Brain
Early Data for T-MAXIMUM's B7-H3 Allogeneic CAR-T in Brain Metastases Presented at WCLC 2026 BEIJING, Sept. 21, 2026 /PRNewswire/ -- As B7-H3 ADCs reshape the second-line treatment landscape for small cell lung cancer at WCLC, a more specific question comes into focus: systemic disease...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Two Vice Presidents Join Castillo Engineering to Scale Utility Solar & Storage Offerings
- U.S. Sec. of State Marco Rubio at NYSE with UNGA in Focus: NYSE Content Update
- Lititz Mutual Selects Guidewire ProNavigator to Bring AI-Powered Guidance to Agents and Employees
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →